ARWR SG&A Expense Growth
Arrowhead Pharmaceuticals Inc · SG&A Expense Growth
ARWR SG&A Expense Growth
Latest reported25.92%period ending
ARWR FY SG&A Growth (YoY) (0.00% → 25.92%)
Latest values, visible window
High-resolution chart · PNG
ARWR sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 25.9192% | |
| 6.4752% | |
| -26.9217% | |
| 53.6546% | |
| 54.9105% | |
| 96.991% | |
| 39.0619% | |
| 9.2886% | |
| -25.996% | |
| -32.0386% | |
| 42.6818% | |
| 108.0984% | |
| -17.0467% | |
| 114.1978% | |
| 112.4114% | |
| -48.119% | |
| -39.4756% | |
| 44.0903% | |
| 33.2496% | |
| -6.8411% | |
| 163.0325% | |
| 2,202.9112% | |
| -36.6739% | |
| 31.5886% | |
| -17.224% | |
| 46.1001% | |
| 15.8413% | |
| -13.0941% | |
| 0% |